$ATYG
Saxon Capital Group, Inc./DE

2021 Q4 Form 10-Q Financial Statement

#000106594921000229 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $25.21K $28.97K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $25.21K $28.97K
YoY Change 216.57%
Operating Profit -$28.97K
YoY Change 216.57%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$25.21K -$28.97K
YoY Change 216.57%
Income Tax
% Of Pretax Income
Net Earnings -$25.21K -$28.97K
YoY Change 216.57%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$4.31 -$4.95
COMMON SHARES
Basic Shares Outstanding 5.851B shares 5.851B shares
Diluted Shares Outstanding 5.851B shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $1.170K $2.920K
YoY Change
Inventory
Prepaid Expenses $1.167K $2.917K
Receivables
Other Receivables
Total Short-Term Assets $1.167K $2.917K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.167K $2.917K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $1.167K $2.917K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.100K $3.150K $9.470K
YoY Change -56.71%
Accrued Expenses $114.0K $99.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $35.64K $28.13K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $153.7K $130.3K $81.47K
YoY Change 88.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $153.7K $130.3K $81.47K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $153.7K $130.3K $81.47K
YoY Change 88.71%
SHAREHOLDERS EQUITY
Retained Earnings -$30.96M -$30.93M -$30.85M
YoY Change 0.36%
Common Stock $58.51K $58.51K $58.51K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$152.6K -$127.4K -$81.47K
YoY Change
Total Liabilities & Shareholders Equity $1.167K $2.917K
YoY Change

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$25.21K -$28.97K
YoY Change 216.57%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$7.510K $10.16K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.510K -9.990K
YoY Change
NET CHANGE
Cash From Operating Activities -7.510K 10.16K
Cash From Investing Activities
Cash From Financing Activities 7.510K -9.990K
Net Change In Cash 0.000 170.0
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$7.510K $10.16K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28966 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-127366 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-44870 USD
us-gaap Net Income Loss
NetIncomeLoss
-27450 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-106362 USD
dei Entity Registrant Name
EntityRegistrantName
Atlas Technology Group, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001093636
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3370795
dei Entity Address Address Line1
EntityAddressAddressLine1
PO Box 147165
dei Entity Address City Or Town
EntityAddressCityOrTown
Lakewood
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80214
dei City Area Code
CityAreaCode
303
dei Local Phone Number
LocalPhoneNumber
323-4896
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5850705874 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2917 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
2917 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
USD
CY2021Q3 us-gaap Assets
Assets
2917 USD
CY2020Q4 us-gaap Assets
Assets
USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3150 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9470 USD
CY2021Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
99000 USD
CY2020Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
72000 USD
CY2021Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
28133 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
130283 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
81470 USD
CY2021Q3 us-gaap Liabilities
Liabilities
130283 USD
CY2020Q4 us-gaap Liabilities
Liabilities
81470 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5850705874 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5850705874 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5850705874 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5850705874 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
58507 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
58507 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-97212 USD
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
000-28675
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28966 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-98400 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30707342 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30530982 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30933115 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30847319 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-127366 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-81470 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2917 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021Q3 us-gaap Revenues
Revenues
USD
CY2020Q3 us-gaap Revenues
Revenues
USD
us-gaap Revenues
Revenues
USD
us-gaap Revenues
Revenues
USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28966 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9150 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
90066 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27450 USD
CY2021Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
USD
CY2020Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
4270 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
28966 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
9150 USD
us-gaap Operating Expenses
OperatingExpenses
85796 USD
us-gaap Operating Expenses
OperatingExpenses
27450 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-28966 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9150 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-85796 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-27450 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9150 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-85796 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27450 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28966 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9150 USD
us-gaap Net Income Loss
NetIncomeLoss
-85796 USD
us-gaap Net Income Loss
NetIncomeLoss
-27450 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5850705874 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5850705874 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5850705874 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5850705874 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9150 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-106362 USD
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 1. NATURE OF OPERATIONS</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Nature of Business</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; margin-bottom:0pt; ">Atlas Technology Group, Inc., a Florida corporation, (“Atlas”, “the Company”, “We", "Us" or “Our’) is a publicly quoted shell company seeking to merge with an entity with experienced management and opportunities for growth in return for shares of our common stock to create values for our shareholders. No potential merger candidate has been identified at this time.</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; margin-bottom:0pt; ">Effective May 29, 2021, we entered into an agreement with Corporate Excellence Consulting Inc. (“CECI”), our then controlling shareholder, and Mr. David Cutler (“Mr. Cutler”) (“the Agreement”) under which:</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; text-indent:36pt; margin-bottom:0pt; ">- </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:-10pt; padding-left:54pt; margin-bottom:0pt; ">CECI surrendered, and we cancelled, the single outstanding share of Series A Preferred Stock. The single outstanding share of Series A Preferred Stock carried super preferred voting rights enabling the holder to vote the equivalent of <span style="-sec-ix-hidden:Fact_222">61%</span> of all voteable preferred and common shares issued and outstanding, </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:36pt; margin-bottom:0pt; ">- </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:-10pt; padding-left:54pt; margin-bottom:0pt; ">We issued a new share of Series A Preferred Stock, carrying the same super preferred voting rights described above, to Mr. Cutler. As a consequence of this issuance, Mr. Cutler became our new controlling shareholder, </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:36pt; margin-bottom:0pt; ">- </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-10pt; text-indent:54pt; margin-bottom:0pt; ">Mr. Cutler was appointed as a director of ours and as our Chief Financial Officer, </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:36pt; margin-bottom:0pt; ">- </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-10pt; text-indent:54pt; margin-bottom:0pt; ">Mr. Cutler paid $5,000 to CECI on our behalf as a partial repayment of the outstanding fees due by us to CECI, </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:36pt; margin-bottom:0pt; ">- </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:-10pt; padding-left:54pt; margin-bottom:0pt; ">Mr. Cutler undertook to pay a further $30,000 on our behalf as a full and final settlement of the outstanding fees due by us to CECI, such payment to be made on the approval by FINRA of a proposed name change and reverse stock split, </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:36pt; margin-bottom:0pt; ">- </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:-10pt; padding-left:54pt; margin-bottom:0pt; ">CECI agreed to accept the $35,000 to be paid to them by Mr. Cutler on our behalf in full and final settlement of the outstanding fees due by us to CECI. </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">The initial payment of $5,000 to CECI was made by Mr. Cutler as agreed.</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">There is no guarantee that it will be possible to complete the remaining terms of the Agreement.</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:22pt; margin-bottom:0pt; "><span style="font-weight:bold; ">History</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; margin-bottom:0pt; ">Atlas was incorporated in the state of Nevada in August 1996 under the name Pan World Corporation. In November 1999, the Company changed its name to Tribeworks, Inc. and redomiciled to the state of Delaware. In August 2007, the Company changed its name to Atlas Technology Group, Inc. In August 2015, the Company redomiciled to the State of Florida. In December 2015, the Company changed its name to Moxie Motion Pictures, Inc. In November 2018, the Company changed its name back to Atlas Technology Group, Inc.</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; margin-bottom:0pt; ">Since its Inception in August 1996, the Company has at various times been involved in the following business activities: software sales, provision of information technology application support services, distribution of energy efficient lighting products and movie production and talent management.</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; ">By December 31, 2018, the Company had ceased all operations and had disposed of all its former operating subsidiaries.</p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:11pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Impact of the COVID-19 Pandemic</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; margin-bottom:0pt; ">We have not commenced operations as yet and consequently have not been directly impacted by the Covid-19 outbreak at this time. However, the detrimental effect of the Covid-19 outbreak on the economy as a whole may have a </p> <div> <div style="width:100%; clear:both;"> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">5</p> </div><hr style="border-top:1.5pt solid #000000;"/><div style="page-break-after:always;"/> <p style="font-size:10pt; text-align:right; font-style:italic; margin-top:auto; "><a href="#toc">Table of Contents</a></p> </div> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:0pt; ">detrimental impact on our ability to raise funding and identify an entity to merge with for the foreseeable future. We are unable to predict with any certainty the ultimate impact Covid-19 outbreak on our plans at this time. </p>
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5850705874 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-81470 USD
atyg Cancellation Of Preferred Stock
CancellationOfPreferredStock
0 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
39900 USD
us-gaap Net Income Loss
NetIncomeLoss
-85796 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-127366 USD
us-gaap Net Income Loss
NetIncomeLoss
-85796 USD
us-gaap Net Income Loss
NetIncomeLoss
-27450 USD
atyg Compensation Paid In Preferred Stock
CompensationPaidInPreferredStock
39900 USD
atyg Compensation Paid In Preferred Stock
CompensationPaidInPreferredStock
USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
4270 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2917 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2050 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
450 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
27000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
27000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28133 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
28133 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28133 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
us-gaap Interest Paid Net
InterestPaidNet
USD
us-gaap Interest Paid Net
InterestPaidNet
USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
us-gaap Net Income Loss
NetIncomeLoss
-85796 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30933115 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:22pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:11pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
CY2020Q4 us-gaap Cash
Cash
0 USD
CY2021Q3 us-gaap Cash
Cash
0 USD
us-gaap Advertising Expense
AdvertisingExpense
0 USD
us-gaap Advertising Expense
AdvertisingExpense
0 USD
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
0 USD
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
0 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3150 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9470 USD
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5850705874 shares
CY2021Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
99000 USD
CY2020Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
72000 USD
CY2021Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
28133 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
USD
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5850705874 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5850705874 shares

Files In Submission

Name View Source Status
0001065949-21-000229-index-headers.html Edgar Link pending
0001065949-21-000229-index.html Edgar Link pending
0001065949-21-000229.txt Edgar Link pending
0001065949-21-000229-xbrl.zip Edgar Link pending
atyg-20210930.xsd Edgar Link pending
atyg-20210930_cal.xml Edgar Link unprocessable
atyg-20210930_def.xml Edgar Link unprocessable
atyg-20210930_lab.xml Edgar Link unprocessable
atyg-20210930_pre.xml Edgar Link unprocessable
atyg10q0921.htm Edgar Link pending
atyg10q0921_htm.xml Edgar Link completed
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending